Multiple Sclerosis Relapse Rates and Healthcare Costs with Generic Glatiramer Acetate: A Retrospective Claims Analysis of US Health Plan Data

被引：0
|
作者：
Kantor, Daniel [1 ]
Grabner, Michael [2 ]
Zhang, Xian [2 ]
Balu, Sanjeev [3 ]
Hall, Steven [3 ]
机构：
[1] Florida Atlantic Univ, Boca Raton, FL 33431 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Sandoz Inc, Princeton, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P129
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [41] Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
    Zeki Kocaata
    Thomas Wilke
    Franz Fischer
    Robert Welte
    Hermann Einsele
    PharmacoEconomics - Open, 2022, 6 : 619 - 628
  • [42] Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
    Kocaata, Zeki
    Wilke, Thomas
    Fischer, Franz
    Welte, Robert
    Einsele, Hermann
    PHARMACOECONOMICS-OPEN, 2022, 6 (04) : 619 - 628
  • [43] Multiple sclerosis relapse in US patients: a population-based analysis of healthcare resource use, productivity and costs in the 30 days post-event
    Lotya, J.
    ONeill, C.
    Ko, J. J.
    Nazareth, T. A.
    Sasane, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 128 - 129
  • [44] Incidence and costs of cardiac device infections: retrospective analysis using German health claims data
    Ludwig, Saskia
    Theis, Cathrin
    Brown, Ben
    Witthohn, Andreas
    Lux, Wolfram
    Goette, Andreas
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (05) : 483 - 492
  • [45] REAL-WORLD COSTS OF ADMINISTERING DISEASE MODIFYING DRUG INFUSIONS AMONG PATIENTS WITH MULTIPLE SCLEROSIS: A US RETROSPECTIVE ADMINISTRATIVE CLAIMS DATABASE ANALYSIS
    Kozma, C. M.
    Roberts, N. L.
    Phillips, A.
    VALUE IN HEALTH, 2020, 23 : S258 - S258
  • [46] Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data
    Ogino, Mieko
    Shiozawa, Aki
    Ota, Hiroyuki
    Okamoto, Shuichi
    Hiroi, Shinzo
    Kawachi, Izumi
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2018, 8 (02) : 97 - 103
  • [47] Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysis
    Fox, Edward
    Vieira, Maria Cecilia
    Johnson, Kristen
    Peeples, Miranda
    Bensimon, Arielle G.
    Signorovitch, James
    Herrera, Vivian
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 398 : 163 - 170
  • [48] ECONOMIC AND COMORBIDITY BURDEN OF PRURIGO NODULARIS AND DRIVERS OF HIGHER HEALTHCARE COSTS IN THE US: A RETROSPECTIVE ANALYSIS OF CLAIMS DATA OF PATIENTS DIAGNOSED BETWEEN 2017 AND 2022
    Elmariah, S.
    Princic, N.
    Richards, M.
    Qureshi, A.
    Sabatelli, L.
    Kwatra, S. G.
    VALUE IN HEALTH, 2024, 27 (06) : S71 - S72
  • [49] Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
    Peter Borchmann
    Jan-Michel Heger
    Jörg Mahlich
    Michael S. Papadimitrious
    Sybille Riou
    Barbara Werner
    Oncology and Therapy, 2023, 11 : 65 - 81
  • [50] Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population
    Gale, Sara L.
    Trinh, Huong
    Mathew, Nitya
    Jahreis, Angelika
    Lin, Celia J. F.
    Sarsour, Khaled
    RHEUMATOLOGY AND THERAPY, 2020, 7 (01) : 89 - 99
12345